Kintegral Advisory’s Zimmer Biomet ZBH Stock Holding History

Kintegral Advisory’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$986K	Hold	11,426	–	–	0.08%	175
2026 Q1	$1.04M	Sell	11,426 -507	-4%	-$46.5K	0.1%	167
2025 Q4	$1.08M	Sell	11,933 -327	-3%	-$31K	0.09%	167
2025 Q3	$1.21M	Sell	12,260 -55	-0.4%	-$5.45K	0.1%	164
2025 Q2	$1.13M	Sell	12,315 -18	-0.1%	-$1.74K	0.1%	171
2025 Q1	$1.4M	Sell	12,333 -42	-0.3%	-$4.49K	0.14%	148
2024 Q4	$1.31M	Sell	12,375 -576	-4%	-$61.8K	0.12%	159
2024 Q3	$1.4M	Sell	12,951 -170	-1%	-$18.6K	0.13%	153
2024 Q2	$1.43M	Buy	13,121 +1,407	+12%	+$166K	0.14%	151
2024 Q1	$1.55M	Sell	11,714 -37	-0.3%	-$4.62K	0.15%	131
2023 Q4	$1.43M	Buy	+11,751	New	+$1.31M	0.16%	136
2019 Q1	–	Sell	-2,104	Closed	-$212K	–	300
2018 Q4	$212K	Buy	+2,104	New	+$237K	0.06%	217

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kintegral Advisory's ZBH Position: Q2 2026 in Review

Kintegral Advisory held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 11,426 shares worth $986K. The position accounts for 0.08% of the portfolio, ranked #175.

Kintegral Advisory first reported a position in ZBH in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.55M in Q1 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Kintegral Advisory held 11,426 shares of Zimmer Biomet worth $986K as of Q2 2026.
Kintegral Advisory left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up 0.08% of Kintegral Advisory's portfolio in Q2 2026, its #175 holding.
Kintegral Advisory first reported a position in Zimmer Biomet in Q4 2018 and has held it in 12 quarters since.
Kintegral Advisory's Zimmer Biomet position peaked at $1.55M in Q1 2024.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.